Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FUQDX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,497
Award facts
- Contract value 100% obligated
- $20,497.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,497.25 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly prescribed for moderate to severe atopic dermatitis, moderate to severe asthma, and other inflammatory conditions, representing a specialized pharmaceutical product within the federal medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs and serves as the mechanism through which AmerisourceBergen supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains extensive experience fulfilling competitively awarded delivery orders across multiple therapeutic domains at varying transaction values.
Quick answers
Who was awarded contract SPE2DB25FUQDX?
SPE2DB25FUQDX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FUQDX worth?
The government has obligated $20,497 on SPE2DB25FUQDX.
Is contract SPE2DB25FUQDX an order under another contract?
Yes. SPE2DB25FUQDX is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQDX competed?
The extent of competition for SPE2DB25FUQDX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award